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Nanoparticles (NPs) are widely used as components of drugs
or cosmetics and hold great promise for biomedicine, yet their
effects on cell physiology remain poorly understood. Here we
demonstrate that clathrin-independent dynamin 2-mediated
caveolar uptake of surface-functionalized silica nanoparticles
(SiNPs) impairs cell viability due to lysosomal dysfunction. We
show that internalized SiNPs accumulate in lysosomes resulting
in inhibition of autophagy-mediated protein turnover and
impaired degradation of internalized epidermal growth factor,
whereas endosomal recycling proceeds unperturbed. This phe-
notype is caused by perturbed delivery of cargo via autophago-
somes and late endosomes to SiNP-filled cathepsin B/L-con-
taining lysosomes rather than elevated lysosomal pH or altered
mTOR activity. Given the importance of autophagy and lyso-
somal protein degradation for cellular proteostasis and clear-
ance of aggregated proteins, these results raise the question of
beneficial use of NPs in biomedicine and beyond.
Nanoparticles (NPs)2 are widely used as components of
drugs or cosmetics and hold great promise as tools in biomed-
icine to improve the detection and treatment of diseases (1). For
example, nanoparticle technology has enabled improvements
in cancer treatment, ranging from improved efficacy of drug
delivery (2) to enhanced immunogenicity of cancer vaccines (3).
Moreover, NPs are used as biosensors and biomarkers (4, 5) or
for DNA/drug delivery (6). Hence, it is necessary to understand
the mechanisms of interaction of NPs with living cells and tis-
sues to assess the biological consequences associated with their
application in biomedicine (7). At present, the risks associated
with the biomedical application of NPs at the cellular and
organismic levels remain incompletely understood (1). Among
the phenotypic changes reported to be associated with the bio-
medical application of NPs are cellular stress responses (i.e.
redox imbalance, oxidative stress), DNA damage, and altered
gene expression (8, 9). Which of these phenotypes can be con-
sidered a direct consequence of cellular NP association or
uptake and the underlying molecular mechanisms have
remained in many cases unknown.
Upon cellular application, NPs initially interact with the
plasma membrane, often followed by their internalization into
the cell interior (10–12) via clathrin-dependent as well as
clathrin-independent endocytosis routes (i.e. via caveolae),
which may require the membrane-severing GTPase dynamin
(13, 14). Due to the questionable specificity of many commonly
used pharmacological tools toward these pathways (15) the pre-
cise mechanisms of cellular uptake of NPs often have remained
elusive. After cell entry NPs are delivered to the endolysosomal
system (16), where they may accumulate. Lysosomes play
essential roles in cell physiology ranging from the degradation
of malfunctional or aggregated proteins (e.g. via autophagy) or
lipids to nutrient signaling and cellular growth control (17). For
example, internalized growth factors such as EGF are sorted to
late endosomes (18), which fuse with lysosomes to deliver their
intralumenal content for degradation (19). It is thus conceiva-
ble that the cellular uptake and accumulation of NPs pro-
foundly impacts on the function of the endolysosomal system
and thereby on cell physiology.
Here we have investigated themechanisms of uptake and the
intracellular trafficking itinerary of silica (SiO2) NPs (SiNPs) in
human cervix carcinoma (HeLa) cells. We demonstrate that
SiNPs are internalized largely via clathrin-independent endo-
cytosis involving dynamin 2-dependent caveolar uptake fol-
lowed by their targeting to and accumulationwithin lysosomes.
We further show that intralysosomal accumulation of SiNPs
severely perturbs autophagy-mediated protein turnover and
degradation of internalized epidermal growth factor due to
impaired cargo delivery via autophagosomes or late multive-
sicular endosomes to SiNP-filled lysosomes. Consistent with
these results we show that lysosomal SiNP accumulation
reduces the metabolic activity of cells although it does not
induce cell death due to apoptosis or necrotic cell lysis. Our
results raise the question of beneficial use of NPs in biomedi-
cine and beyond.
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Results
To address the mechanism of cellular uptake and the physi-
ological consequence of NP accumulation in mammalian cells
we prepared SiNPs covalently labeled with FITC by modified
microemulsion synthesis (20). The resulting dye-labeled
spheres were used as cores for the subsequent seeded growth of
a silica shell of 3-nm thickness based on the Stöbermethod (21).
The surface of FITC-labeled SiNPs was modified by amino
functionalization with N-(6-aminohexyl)-aminopropyltrim-
ethoxysilane (AHAPS), resulting in the covalent introduction
of positively charged amino groups (Scheme 1) that facilitate
cellular uptake and counteract aggregation of SiNPs (22). The
resulting AHAPS-functionalized SiNPs were homogenously
sized spheres with an average diameter of 75 2 nm and a zeta
potential of 51 1mV in ethanol and of 119 2-nm and a zeta
potential of 25  1 mV in water (Fig. 1A, Table 1). AHAPS-
modified SiNPs showed excellent colloidal stability in ethanol
and in cell culture media.
To study the mechanism of SiNP uptake, cultured HeLa
human cervix carcinoma cells were incubated for 4 h at 37 °C
with FITC-labeled SiNPs, washed, and fixed. Analysis by con-
focal spinning disc microscopy revealed the accumulation of
SiNPs in spherical intracellular organelles enriched in the peri-
nuclear area. To unravel the mechanism of SiNP uptake, cells
were treatedwith small interfering (si) RNAs to deplete themof
endogenous clathrin heavy chain, a key essential component of
clathrin-mediated endocytosis, flotillin 1, an integral mem-
brane protein thought to contribute to clathrin-independent
fluid-phase endocytosis via the CLIC/GEEC pathway (23, 24),
or of caveolin, the main structural component of caveolae that
undergoes dynamin-mediated fission (25). RNA interference
resulted in the efficient and specific down-regulation of the
corresponding target proteins by 85–90% (Fig. 1B). SiNP endo-
cytosis was greatly reduced in HeLa cells depleted of caveolin 1
(using either smart pool siRNAs or a distinct single siRNA) or of
dynamin 2. Knockdown of flotillin 1 led a small although statis-
tically significant reduction in SiNP uptake, whereas SiNP
endocytosis proceeded unperturbed in the absence of clathrin.
Thus, AHAPS-modified SiNPs enter HeLa cells primarily via
dynamin2-mediatedcaveolarendocytosis (Fig.1,CandD) inde-
pendent of clathrin.
Internalized SiNPs displayed a punctuate distribution with
some enrichment in the perinuclear area, suggestive of their
accumulation within intracellular organelles. Intracellular
SiNPs colocalized with CD63 and LAMP1, transmembrane
proteins that partition between late endosomes and lysosomes
(26), but not with early endosomes containing early endosomal
antigen 1 (EEA1) (Fig. 2, A and B). Limited colocalization was
observed with the clathrin adaptor AP-1 (assembly protein 1)
and with the mannose 6-phosphate receptor (MPR), proteins
that cycle between endosomes and the trans-Golgi network
(26) (Fig. 2, A and B). No colocalization of internalized SiNPs
with the Golgi complex, mitochondria, or the endoplasmic
reticulum was detected (data not shown), in agreement with
Al-Rawi et al. (27). The accumulation of SiNPs in late endo-
somes/lysosomes was also observed in living cells incubated
with LysoTracker Red (Fig. 2, A and B), an organic heterotricy-
clic 4-bora-3a,4a-diaza-s-indacene compound that accumu-
lates within the acidic lumen of late endosomes/lysosomes.
Ultrastructural analysis of HeLa cells by thin-section electron
microscopy confirmed the prominent accumulation of SiNPs
within the lumen of lysosomes (Fig. 2C). Lysosomal accumula-
tion of SiNPs was paralleled by decreased metabolic activity as
evidenced by the reduced ability of SiNP-treated HeLa cells to
reduce the tetrazoliumdyeMTT (Fig. 3A). However, we did not
detect pronounced cell death via apoptosis (Fig. 3B) or necrotic
cell membrane permeabilization (Fig. 3C) induced by accumu-
lation of SiNPs. Thus, dynamin 2-mediated caveolar endocyto-
sis of SiNPs into HeLa cells resulted in their accumulation in
late endosomes and lysosomes and in reduced metabolic activ-
ity of cells (consistent with Refs. 27 and 28).
The high level accumulation of SiNPs within lysosomes con-
ceivablymay perturb lysosomal function. Lysosomes are essen-
tial eukaryotic organelles that serve as endpoints for the degra-
dation of internalized growth factors such as epidermal growth
factor (EGF) (18) and for cytoplasmic material (i.e. aggregated
proteins) targeted for autophagy, a pathway intimately linked to
cellular growth control (29). Autophagy requires the posttrans-
lational lipidation of cytoplasmic LC3 protein with phospha-
tidylethanolamine (a form termed LC3-II), resulting in its
association with membranes and autophagosome formation.
Modified LC3-II then undergoes degradation as autophago-
somes fuse with lysosomes to enable degradation (29). Incuba-
tion of HeLa cells with increasing concentrations of SiNPs
showed a concomitant increase in lipidated LC3-II protein (Fig.
4A) and in the number of LC3-positive autophagosomes (Fig.
4B). A similar cellular accumulation was seen for p62
(SQSTM1) (29), another component of autophagosomes and
substrate for autophagy-mediated lysosomal protein turnover
(Fig. 4, A and C). As expected, LC3-positive autophagosomes
displayed little overlapwith LAMP1-containing lysosomes (Fig.
4E). An accumulation of LC3-containing autophagosomes was
also seen in HeLa cells treated with iron-oxide NPs coated with
polyethylene glycol (PEG) (Fig. 4D), suggesting that accumula-
tion of autophagosomes may be a general phenotype induced
by treatment of cells with high doses of NPs.
To further explore the mechanism underlying the observed
autophagosome accumulation in SiNP-treated cells, we ana-
lyzed the effects of serum starvation, conditions that induce
autophagosome formation, and of the vacuolar ATPase inhibi-
SCHEME 1. Scheme illustrating the synthesis of AHAPS-functionalized SiNPs using the microemulsion and Stöber technique (see “Experimental
Procedures”).
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tor bafilomycin A1, which blocks lysosomal degradation by dis-
sipating the lysosomal proton gradient. Starvation of control
cells resulted in increased levels of lipidated LC3-II due to the
accumulation of LC3-positive autophagosomes, and this phe-
notype was exacerbated by concomitant application of bafilo-
mycin A1 to prevent lysosomal turnover of autophagosomes
(Fig. 5, A and C). Cells treated with SiNPs displayed high levels
of lipidated LC3-II and accumulated LC3-positive autophago-
somes under all conditions, largely irrespective of whether cells
had been starved and/or treated with bafilomycin A1 (Fig. 5, A
and C). Treatment of cells with non-fluorescent, unlabeled
SiNPs also caused LC3-II to accumulate (Fig. 5B). These data
suggest that lysosomal accumulation of SiNPswithin cells is not
due to enhanced autophagosome formation but may rather
reflect defective autophagic flux.
Consistent with these results, we found that accumulation of
autophagosomes and of p62 were not a consequence of altered
FIGURE 1. SiNPs are internalized largely via dynamin 2-mediated caveolar endocytosis. A, transmission electron microscopy images and corresponding
size distributions of FITC-labeled SiNPs (a, left) and non-labeled SiNPs (b, right) functionalizedwith AHAPS. Scale bar, 200 nm. B, representative immunoblots of
HeLa cell lysates after treatment with siRNA. Protein levels for clathrin (4.9  2.6% of control), flotillin 1 (15.0  0.9% of control), caveolin 1 (5.1  0.9% of
control), or caveolin 1 smartpool (4.4  3.6% of control) and dynamin 2 (5% of control) were determined using Image J software. C, quantification of SiNP
uptake as shown inD. Depicted is themean SiNP fluorescence intensity of HeLa cells treatedwith siRNAs against clathrin (91.8 6.8%), flotillin 1 (84.7 2.0%),
caveolin 1 (52.8 8.2% for single or 62.9 8.8% for smartpool siRNA), or dynamin 2 (49.9 10.3%) (n 3–10 independent experiments; *, p 0.05; **, p
0.01). ns, not significant. D, Representative confocal microscopy images of HeLa cells incubated with SiNPs after depletion of clathrin, flotillin 1, caveolin 1
(single or smartpool siRNA), or dynamin 2. Scale bar, 10 m.
TABLE 1
Characterization of SiNPs with () and without () FITC in the core
Data are from n 5 independentmeasurements (at 25 °C, inDMEM(10%FCS) at
37 °C) performed within the first hour after transfer into the corresponding
medium. TRM, transmission electronmicroscopy; DLS, differential light scattering.
Ø diameter;  zeta potential.
Nanoparticle type
Ethanol Water
DMEM
( 10% FCS)
Ø/nm
(TEM)
Ø/nm
(DLS) /mV
Ø/nm
(DLS) /mV
Ø/nm
(DLS)
SiNPs (FITC) 75 2 107 1 51 1 119 2 25 1 245 4
SiNPs (FITC) 52 2 105 3 37 7 118 6 33 2 150 15
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mTOR signaling, a key regulatory pathway of autophagy, as the
cellular accumulation of SiNPs did not alter the levels of
phospho-S6K1 or phospho-ULK1 (Fig. 6). We conclude that
intralysosomal accumulation of SiNPs leads to the accumula-
tion of p62-containing LC3-positive autophagosomes that
apparently fail to undergo further lysosomal degradation as fur-
ther explored in detail below (see Fig. 9).
Although these results indicate that cellular accumulation of
SiNPs impairs degradation of cytoplasmic proteins targeted for
lysosomal degradation via autophagy, they do not address
whether growth factors internalized from the plasma mem-
brane via endosomes can be degraded efficiently in SiNP-filled
lysosomes.We, therefore, analyzed the uptake and degradation
of Alexa647-labeled EGF. Endocytosis of EGF-Alexa647 into
HeLa cells proceeded unaltered irrespective of whether or not
these cells had been incubated with SiNPs before EGF addition
(Fig. 7C, 30 min). SiNP-treated cells also showed normal sur-
face levels of EGF receptors, and ligand binding to these recep-
tors elicited a signaling response similar to that of control cells
(Fig. 7, D and E). However, SiNP-containing HeLa cells dis-
played a strongly reduced ability to degrade internalized EGF-
Alexa647 during the subsequent post-endocytic chase period of
60 or 120 min (Fig. 7C). Instead of being rapidly degraded, a
significant fraction of internalized EGF-Alexa647 remained
within punctuate structures identified by multicolor confocal
microscopy as LAMP1- and CD63-positive late endosomes
even after a 120-min chase (Fig. 7, F and G). This effect was
specific for the lysosomal system as endocytosis and recycling
FIGURE 2. SiNPs accumulated in lysosomes.A, confocalmicroscopy images of HeLa cells illustrating the subcellular localization of internalized SiNPs after 4 h
(green channel) and various organellarmarkers (red channel). EEA1 and the caveolarmarker protein caveolin-1 do not colocalize with internalized SiNPs. There
is a partial colocalizationof SiNPswith the trans-Golgi network/endosomal proteinsAP-1 andmannose 6-phosphate receptor (M6PR). SiNPs strongly colocalize
with the lysosomal membrane protein LAMP1 and CD63. A profound colocalization of SiNPs with lysosomes was also observed in living cells after incubation
with LysoTracker Red. Scale bar, 10m. B, Pearson’s correlation coefficients of SiNPswith different organellarmarkers: EEA1 (early endosomes), 0.080 0.014;
caveolin 1 (caveolae), 0.068 0.001; AP-1 (trans-Golgi network/recycling endosomes), 0.161 0.032; M6PR (trans-Golgi network/endosomes), 0.212 0.008;
LAMP1 (late endosomes/lysosomes), 0.396 0.023; CD63 (late endosomes/lysosomes), 0.474 0.012; LysoTracker (lysosomes), 0.439 0.021. n 3 inde-
pendent experiments. C, electron micrographs of lysosomes acquired after 4 h (left) or 24 h (right) of HeLa cell incubation with SiNPs. Scale bars, 500 nm.
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of transferrin, an iron-carrying protein not degraded via lyso-
somes, fromendosomes to thecell surfaceproceededunperturbed
(Fig. 7, A and B). Intralysosomal accumulation of SiNPs in HeLa
cells, thus, disrupts the lysosomal degradation of internalized EGF
and likely of other growth and differentiation factors.
What might be the reason for the failure of SiNP-filled lyso-
somes to degrade cytoplasmic autophagic substrates or inter-
nalized growth factors? Several scenarios can be envisioned.
Lysosomes containing AHAPS-modified SiNPs may be dys-
functional because their proton gradient is disrupted due to the
accumulation of charge, sequestration of ions required for acid-
ification (i.e.Cl), or loss of membrane integrity. Such changes
would eventually result in the inactivity of intralysosomal
hydrolases (17). Alternatively, SiNP-filled lysosomes may be
unable to receive cargo from upstream donor compartments
such as autophagosomes and late endosomes, i.e. due to the
inability of their limiting membrane to undergo remodeling
required for fusion, resulting in the spatial segregation of
lysosomes from their target substrates (19). We tested these
possibilities by first analyzing lysosomal pH in living cells.
Ratiometric imaging using pH-sensitive Oregon Green488
coupled to 10-kDa dextran (30) revealed an intralysosomal
pH of 4.5  0.1 in control cells and of 3.9  0.1 in SiNP-
loaded cells (Fig. 8, A–C). The slightly lower pH of SiNP-
loaded lysosomes possibly is a secondary consequence
resulting from the failure of these lysosomes to degrade intra-
cellular proteins, which serve as the main lumenal buffer for pro-
tons. Consistent with this and with the fact that most lysosomal
hydrolases are activated by low pH, we observed elevated cathep-
sin B andL activities in SiNP-loaded cells (Fig. 8,D–F). These data
show that dysfunction of SiNP-filled lysosomes is not the result of
impaired lysosomal acidification or inactivity of intralysosomal
hydrolases.
We, therefore, finally tested the hypothesis that impaired
autophagy and lysosomal degradation result from impaired
cargo delivery to lysosomes from upstream donor compart-
ments such as autophagosomes and late endosomes. If this
indeed were the case, one would expect that substrates for lys-
osomal proteolysis such as LC3-II, p62, and internalized EGF
accumulate in compartments lacking SiNPs as well as func-
tional lysosomal hydrolases. Multicolor confocal imaging
indeed revealed the near complete lack of colocalization
between LC3-, p62-, and SiNP-containing lysosomes (e.g. pos-
itive for cathepsin B/L), whereas SiNPs displayed a profound
overlap with lysosomal cathepsin B and L hydrolase activities
(Fig. 9, A and B). To directly test the hypothesis that impaired
autophagy and lysosomal degradation result from impaired
cargo delivery to lysosomes from upstream compartments, we
used tandem RFP-GFP-tagged LC3. Fusion of RFP-GFP-LC3
with lysosomes results in quenching of GFP fluorescence and,
thus, has been widely used to monitor autophagic flux and
autolysosome formation. Serum starvation induced autolysosome
formation in control cells, and this was completely blocked by
treatment of cells with the vacuolar ATPase inhibitor bafilomycin
A1 as expected (Fig. 9C, no NPs). By contrast, autolysosome for-
mation was significantly impaired in SiNP-treated cells irrespec-
tive of whether cells were fed or serum-starved (Fig. 9C, 100
g/ml NPs).
Collectively, these data demonstrate that impaired auto-
phagic protein turnover anddegradation of internalized growth
factors in SiNP-treated cells likely results from inhibition of
cargo delivery via autophagosomes and late endosomes to
SiNP-filled lysosomes.
FIGURE 3. SiNPs accumulation in lysosomes reduced metabolic activity
but did not induce apoptotic or necrotic death of cells. A, reduced
metabolic activity of SiNP-treated (24 h) HeLa cells assayed by MTT. Via-
bility was determined for cells treated with 2 g ml1 SiNPs (85.0 9.4%
(FITC) and 83.1  4.9% (FITC)) with 5 g ml1 SiNPs (68.8 
7.6% (FITC) and 74.0  5.8% (FITC)), with 20 g ml1 SiNPs (62.3 
4.8% (FITC) and 63.2  2.9% (FITC)), and 100 g ml1 SiNPs (55.8  4.0%
(FITC) and58.02.6% (FITC), respectively).ns, non-significant; *,p0.05;
**, p  0.01; ***, p  0.001. B, SiNP treatment of HeLa cells does not induce
apoptotic cell death. Apoptotic cell death of HeLa cells treated for 24 h with
20 g ml1 or 100 g ml1 SiNPs analyzed by TUNEL staining. Cells treated
withDNase I for 15min served as a positive control.C, SiNP treatment of HeLa
cells does not induce necrotic cell death. Necrotic cell death of HeLa cells
treated for 24 h with 20 g ml1 or 100 g ml1 SiNPs analyzed by lactate
dehydrogenase (LDH) release into themedium. Lactatedehydrogenaseactiv-
ity released by complete lysis of HeLa cells after treatment with 1% Triton
X-100 was set to 100%.
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FIGURE 4. Effects on autophagy in SiNP-loaded cells. A, immunoblot analysis of control cells or cells treated with 20 g/ml SiNPs (NPs (low)) or 100 g/ml
SiNPs (NPs (high)) for LC3-I (inactive precursor), LC3-II (the active autophagosome-associated form), and p62. The LC3-II/LC3-I ratio was quantified and
normalized to control cells: control (set to 1); NPs (low) (3.1 0.9); NPs (high) (5.0 1.2). p62 quantification: control (set to 1); NPs (low) (3.04 1.4); NPs (high)
(6.38 3.9). n 4 independent experiments; *, p 0.05. B, left, confocal images of control or SiNP-treated HeLa cells (low, 20g/ml; high, 100g/ml) stained
for the autophagosomalmarker LC3.Right, quantificationof LC3 intensity levels in control cells (set to 100%) and in cells incubatedwith lowNPs (129.14.6%)
and high NPs (274.8  58.6%). Values represent the mean  S.E. for n  4 independent experiments; *, p  0.05. C, left, confocal images of control or
SiNP-treated HeLa cells (low, 20g/ml; high, 100g/ml) stained for the autophagicmarker p62. Right, quantification of p62 intensity levels in control cells (set
to 100%) and in cells incubatedwith lowNPs (260.9 42.4%) andwith highNPs (313.3 55.4%). Data representmean S.E., n 3 independent experiments;
*,p0.05.D, left, confocal imagesof control or Fe2O3-NP-treatedHeLa cells (low, 20g/ml;high, 100g/ml) stained for theautophagosomalmarker LC3.Right,
quantification of LC3 intensity levels in control cells (set to 100%) and in cells incubated with low NPs (177.87 65.3%) and with high NPs (182.64 78.3%).
Data represent mean S.E., n 2 independent experiments. E, representative confocal images of HeLa cells treated or not with 100g/ml SiNPs (NPs (high))
and co-stained for LC-3 and LAMP1. Scale bar, 10 m.
Nanoparticle-induced Lysosomal Dysfunction
JULY 1, 2016•VOLUME 291•NUMBER 27 JOURNAL OF BIOLOGICAL CHEMISTRY 14175
 at M
ax-D
elbrück-Centrum
 für M
olekulare M
edizin on M
ay 8, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIGURE 5. SiNPs induced the accumulation of autophagy markers by blocking autophagic flux. A, untreated or treated HeLa cells with 100 g/ml
FITC-labeled SiNPs (FITC-NPs) for 24 h were incubated in complete DMEMmedium and in serum-free starvationmedium for 4 h in the presence or absence of
bafilomycin A1 and then analyzed byWestern blotting for the autophagosomalmarker LC3. The LC3-II/LC3-I ratiowas quantified and normalized to untreated
control cells. Shown are non-starved control cells (set to 1), starved control cells (2.52 0.2), starved control cells treatedwith 100 nM bafilomycin A1 (4.002
0.5), non-starved cells incubated with FITC-NPs (3.98 0.87), starved FITC-NPs-treated cells in the absence (4.84 1) or presence of 100 nM bafilomycin A1
(5.131.2). Data are themean S.E.;n4 independent experiments; *,p0.05.B, untreatedor treatedHeLa cellswith 100g/mlnon-labeledSiNPs (NL-NPs)
were incubated as above and then analyzed by Western blotting LC3. The LC3-II/LC3-I ratio was quantified and normalized to untreated control cells. Shown
are non-starved control cells (set to 1), starved control cells (1.69 0.2), starved control cells treatedwith 100 nM bafilomycin A1 (3.49 0.3), non-starved cells
incubated with NL-NPs (2.41 0.2), starved NL-NP-treated cells in the absence (2.83 0.5) or presence of 100 nM bafilomycin A1 (3.76 0.4). Data are the
mean S.E.; n 4 independent experiments; *, p 0.05; ***, p 0.001. C, left, confocal images of untreated or treated HeLa cells with 100g/ml FITC-NPs or
NL-NPs and incubated as above. After fixation, cells were stained for LC3. Right, quantification of LC3 puncta per cell of every condition: non-starved control
cells (21.37 10), starved control cells (53.63 19), starved control cells treated with 100 nM bafilomycin A1 (80.61 16.6), non-starved cells incubated with
FITC-NPs (75.56  4.5), starved FITC-NP-treated cells in the absence (74.99  7.5) or presence of 100 nM bafilomycin A1 (66.11  3.5), non-starved cells
incubatedwith NL-NPs (84.72 13.3), starved NL-NP-treated cells in the absence (67.47 11.7) or presence of 100 nM bafilomycin A1 (76.96 18.7). Data are
the mean S.E.; n 3 independent experiments; *, p 0.05.
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Discussion
Wedemonstrate using siRNA-mediated cellular depletion of
key endocytic proteins that positively charged SiNPs enter cells
largely (though perhaps not exclusively) via dynamin 2-depen-
dent caveolar internalization rather than clathrin-mediated
endocytosis in contrast to a previous study (12). We also
observed a small inhibitory effect of flotillin 1 depletion on
SiNPuptake thatmay reflect a secondary caveolin-independent
endocytic pathway or, alternatively, the use of shared compo-
nents of caveolar- and CLIC/GEEC-mediated endocytosis
described recently (31).
The most important conclusion that emanates from our
work is the fact that positively charged SiNPs and by extension
other SiNPs that accumulate in lysosomes (28), although gen-
erally perceived as being well tolerated by mammalian cells,
accumulate in lysosomes over extended periods of times (we
have followed them for days without loss of signal) causing
impairment of lysosomal function, a pathway not addressed in
prior studies (for example, see Refs. 27 and 28). Several lines of
evidence support this. First, we show that lysosomal accumula-
tion of SiNPs causes the accumulation of LC3- and p62-positive
autophagosomes that fail to undergo lysosomal degradation,
suggesting that degradation of cytosolic proteins via autophagy
is perturbed. Second, we demonstrate that SiNP-treated cells
partially fail to degrade exogenous ligands such as growth fac-
tors (i.e. EGF), which instead accumulate in late endosomes. By
contrast, endosomal recycling proceeds unperturbed, indicat-
ing that SiNP-induced alterations within the endosomal system
are specific for degradative sorting. Degradation of internalized
growth and differentiation factors is an important means of
mammalian cells to control cell growth and entry into mitosis
(18). Third, we show that failed lysosomal proteolysis of EGF or
autophagosomal substrates does not result from altered mTOR
signaling, elevated intralysosomal pH, or general damage of lyso-
somal membranes. Furthermore, qualitative cathepsin activity
assays argue against SiNP-induced impairment of lysosomal pro-
tease activity, although quantitative effects of SiNPs on cathepsin
trafficking or activation cannot be ruled out completely.
Rather, we favor a model according to which lysosomes con-
taining high levels of SiNPs fail to receive cargo from late endo-
somes and autophagosomes, i.e. due to defective fusion of
these organelles with lysosomes (Fig. 10) as evidenced by the
observed spatial segregation of non-degraded EGF or p62
and lysosomal proteases (Fig. 9, A and B) and the impaired
autophagic flux and autolysosome formation (Fig. 9C) in
SiNP-treated cells. At the moment we can only speculate
why SiNP-containing lysosomes maybe fusion-defective.
One possibility is that the rigid structure of SiNPs, perhaps paired
with electrostatic interactions of their positively charged surface
with negatively charged glycolipids lining the lumenal face of lys-
osomalmembranes (32),maypreventmembrane remodelingpro-
cesses that are required for SNARE-mediated fusion with late
endosomesor autophagosomes (33).Consistentwith thispossibil-
ity, it has been observed that membrane fission at the plasma
membrane is regulated by the specific lipid environment (34).
However, other mechanisms of SiNP action on lysosomal fusion
cannot be ruled out.
Given that lysosomal function is key to many aspects of cell
physiology, most notably the clearance of degradation-prone (i.e.
internalized growth factors), aggregated malfunctional proteins
(17, 29, 35),wehypothesize that the adverse effects of SiNPson the
metabolic activity of cells are a direct consequence of lysosomal
dysfunction. Accumulation of NPs in cells, in particular in the
brain, apart from the effects on cell metabolism may potentially
also affect the clearance of aggregated proteins via autophagy and,
thus, favor neurodegenerative disorders such as Morbus
Alzheimer, Huntington disease, or Parkinson disease (35). Irre-
spective of whether some or all of these effects are of clinical rele-
FIGURE 6. Lysosomal SiNP accumulation did not altermTORC1 signaling. A, left, immunoblot analysis of control cells or cells treatedwith 100g/ml SiNPs
for phospho-ULK1 (Ser-757) and phospho-p70 S6K (Thr-389). Baf A1 (100 nM) was added to the medium (for 4 h) where indicated. Actin served as loading
control.Middle, quantification of phospho-ULK1: non-starved (set to 1), non-starved Baf A1 (1.12 0.06), starved (0.22 0.08), SiNPs (1.12 0.08), SiNPs
Baf A1 (1.26 0.19). Right, quantification of phospho-S6K: non-starved (set to 1), non-starved Baf A1 (0.72 0.10), starved (0.40 0.07), SiNPs (0.93 0.10),
SiNPs Baf A1 (0.90 0.07). B, left, immunoblot analysis of control cells or cells treatedwith 100g/ml SiNPs of SiNPs for total levels of ULK1 and p70 S6K. Baf
A1 (100 nM)was added to themedium (for 4 h)where indicated. Actin served as the loading control.Middle, quantification of total-ULK1: non-starved (set to 1),
non-starved Baf A1 (1.4 0.2), starved (0.9 0.1), NPs (1.6 0.3), NPs Baf A1 (1.4 0.4). Right, quantification of total p70 S6K: non-starved (set to 1),
non-starved Baf A1 (1.2 0.2), starved (1.0 0.2), NPs (1.0 0.1), NPs Baf A1 (1.2 0.2). Data are presented as the mean S.E. for n 3 independent
experiments; *, p 0.05; **, p 0.01; ***, p 0.001.
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vance, our data call for a reassessment of the risk associated with
the application of SiNPs in biomedicine.
Experimental Procedures
NP Synthesis and Characterization (Transmission Electron
Microscopy, Dynamic Scattering, Zeta Potential)
The synthesis and characterization of SiNPs were performed
as previously described (22). Super-paramagnetic Fe2O3-NPs
were a kind gift of MagForce AG (Berlin).
Cell Culture and Transfection
HeLa cells were grown in low glucose Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal
bovine serum (FBS), 1% glutamine, and 1% penicillin/strepto-
mycin and cultured at 37 °C, 5%CO2. SiRNA transfectionswere
done with Oligofectamine (Invitrogen). HeLa cells were
transfected with the mRFP-GFP-LC3 plasmid using lipo-
fectamine2000 (Invitrogen). After transfection, cells were
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FIGURE 7. SiNP accumulation did not affect endocytosis or recycling of Tf but impaired EGF degradation and resulted in the accumulation of non-
degradedEGF in lateendosomes.A, confocalmicroscopy images showAlexa647-transferrin (Tf-647) levels in control (ctrl) andSiNP-treated (NPs) HeLa cells
at three different time points. Nuclei were stained with DAPI (blue). Quantified is the Tf-647 fluorescence intensity in cells incubated with SiNPs (NPs)
comparedwith control cells (ctrl). Intensity values at 5minwere set to 100% tomonitor the recycling process. At 15min post-chasewith unlabeled Tf the levels
of Tf-647were reduced to 52 17% in control cells versus 47 11% in SiNP-treated cells. At 60min post-chasewith unlabeled Tf levels of Tf-647were reduced
to 12 4% in control (control) cells versus14 9% in SiNP-treated cells. Data represent themean S.E., n 3 independent experiments. Scale bar, 10m. ns,
not significant.B, unaltered surface levels of Tf receptors in control (ctrl) (set to100%) andSiNP-treatedHeLa cells (NPs) (1158%,nsnon-significant). HeLa
cells were incubated with Tf-647 at 4 °C to allow for Tf receptor engagement in the absence of internalization, washed extensively, and analyzed by immuno-
fluorescence microscopy. Data represent the mean  S.E., n  4 independent experiments. C, left, confocal images of Alexa647-EGF (red) internalized into
control (ctrl) or SiNP (green)-treatedHeLa cells chased for the indicated timepoints post-internalization. DAPI (blue), nuclei.Right, quantitationof Alexa647-EGF
fluorescence intensity of control (ctrl) or SiNP-treated HeLa cells (NPs, either FITC-labeled (FITC) or unlabeled (FITC)). Intensity values at 30 min were set
to 100%. Degradation of EGF was significantly impaired at 60min (EGF remaining: control (8.4 1.9%) versusNPFITC (52.4 9.6%); NPFITC, 42.3 4.5%)
and 120min of chase (EGF remaining: control (2.2 0.7%) versusNPFITC (26.3 1.3%) andNPFITC, 30.1 4.8%] in SiNP-treated cells. Data are themean
S.E., n 3 independent experiments; *, p 0.05; **, p 0.01; ***, p 0.001. Scale bar, 10 m. D, unaltered surface levels of EGF receptors in control (ctrl) (set
to 100%) and SiNP-treated HeLa cells (NPs) (93.3 5.3%) kept at 4 °C. Data are the mean S.E., n 4 independent experiments. E, immunoblot analysis of
EGF signaling responses of control (ctrl) or SiNP-treated HeLa cells. Shown are immunoblots for: phosphorylated EGF receptor (pEGFR), total EGF receptor
(EGFR), phosphorylated Erk1/2 kinase (pErk 1/2), and total Erk1/2 kinase (Erk). Hsp70 served as the loading control. F, non-degraded EGF accumulates in late
endosomes. Confocalmicroscopy analysis of the localizationof non-degradedAlexa647-EGFaccumulated in SiNP-treatedHeLa cells. FractionofAlexa647-EGF
in immunopositive compartments: LAMP1 (late endosomes/lysosomes), 47.79  0.09%; CD63 (late endosomes/lysosomes), 55.38  0.08%; EEA1 (early
endosomes), 17.22 0.03%; p62 (autophagosomes), 7.43 3.42%; M6PR (trans-Golgi network/endosomes), 7.48 1.49%; LC3 (autophagosomes), 7.16
1.83%. Data are the mean S.E., n 3 independent experiments. G, non-degraded EGF accumulates in late endosomes. Representative confocal images of
SiNPs-treated HeLa cells 120 min after the addition of Alexa647-EGF. To assess the localization of non-degraded EGF, cells were counterstained for different
organellar markers: LAMP1 (late endosomes/lysosomes), CD63 (late endosomes/lysosomes), EEA1 (early endosomes), p62 (autophagosomes), M6PR (trans-
Golgi network/endosomes), or LC3 (autophagosomes). Scale bar, 10 m.
FIGURE 8. Effects of SiNP accumulation in lysosomes on lysosomal acidification and cathepsin activity. A, representative confocal images showing
colocalization of OGDwith the late endosomal/lysosomalmarker CD63 in control (ctrl) and SiNP-treatedHeLa cells shownby confocal imaging. B, quantitative
analysis of data shown in A. Pearson’s correlation coefficients were determined for OGD and CD63 (ctrl, 0.41 0.03;NPs, 0.49 0.05, respectively) and OGD
and LAMP1 (control, 0.42  0.06; NPs, 0.40  0.05, respectively), mean  S.E.; n  3 independent experiments. C, SiNP accumulation does not impair
lysosomal acidification. Ratiometric measurement of intralysosomal pH of control (ctrl, pH 3.9 0.1) or SiNP-treated HeLa cells (NPs, pH 4.5 0.1) Data are
themean S.E.; n 5 independent experiments; **, p 0.01.D and E, live cell confocal images show the localization of hydrolyzed fluorescent cathepsin B (D)
or cathepsin L (E) products (red) in the control (upper panel) and SiNP (green)-treatedHeLa cells (lower panel). Elevated activities of cathepsins B (259.8 56.1%)
and L (306.5 84.5%) in SiNP-treated HeLa cells compared with controls (set to 100%). Data are themean S.E., n 3 independent experiments; *, p 0.05.
ns, not significant.
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FIGURE 9. Lysosomal accumulation of SiNPs impaired autophagosome-lysosome fusion. A, representative confocal images depicting the distribution of
LC3, p62 and cathepsin B (red channel)- in FITC-SiNP (green)-treated HeLa cells. Scale bars, 10 m. B, quantitative analysis of data shown in A. Pearson’s
correlation analysis shows lack of colocalization between LC3 (0.111 0.006) and p62 (0.005 0.031) with SiNPs. Fluorescent cathepsin products strongly
colocalizewith SiNPs (0.58 0.04 for cathepsin B and 0.51 0.05 for cathepsin L). Data are themean S.E., n 3 independent experiments.C, HeLa cellswere
transiently transfected with an RFP-GFP tandem fluorescent-tagged LC3. After 24 h, cells were or not treated with 100 g/ml non-labeled siNPs for 24 h and
incubated in complete DMEMmedium and in serum-free starvation medium for 4 h in the presence or absence of bafilomycin A1 (100 nM). Left, live confocal
images of the different treatments as indicated. Right, the number of yellow puncta (autophagosomes) and the number of RFP LC3-positive puncta (autoly-
sosomes) in the merged images were counted, and the total number of puncta per cell was calculated as percentage. Data are presented as the mean S.E.,
n 3 independent experiments; *, p 0.05.
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treated with siNPs for 24 h. Because of the fact that the GFP
signal is quenched in acidic compartments, this probe makes it
possible to differentiate between autophagosomes (GFP-posi-
tive and RFP-positive or yellow puncta) and autolysosomes
(GFP-negative and RFP-positive or red puncta). Twenty cells
were analyzed per assay in ImageJ.
SiNP Uptake, Immunocytochemistry, and Fluorescence
Microscopy
HeLa cells grown on poly-(L-lysine)-coated glass coverslips
were washed with PBS and incubated at 37 °C and 5% CO2 for
4 h in DMEM (10% FBS) supplemented with 20 g ml1
SiNPs. After washing with PBS (10 mM MgCl2), cells were
fixed with 4% paraformaldehyde for 10 min at room tempera-
ture, permeabilized, blocked in goat serum dilution buffer (30%
goat serum, 0.1% Triton X-100 in sodium phosphate buffer, pH
7.4), and antibody-stained. Samples were imaged on a Zeiss
Axiovert 200M-based spinning disk confocal microscope
(PerkinElmer Life Sciences) under the control of Volocity
(Improvision Inc.).
Antibodies; siRNAs
The following antibodies were used in this study: EEA1
(mouse, BD Transduction Laboratories), LAMP1 (mouse,
clone CD107a/H4A3, Pharmingen), caveolin1 (mouse, BD
Transduction Laboratories; and rabbit, Santa Cruz Biotechnol-
ogy), clathrin (mouse, clone TD1; homemade antibody), flotil-
lin1 (mouse, BD Transduction Laboratories), dynamin 1  2
(mouse, BD Biosciences), actin (mouse, clone ac15, Sigma),
Hsp70 (mouse, Affinity BioReagents), mannose 6-phosphate
receptor (mouse, CI-M6PR, Affinity BioReagents), CD63
(mouse, clone RFAC4, Millipore), AP-1 (mouse, 100/3, Sigma),
LC3 for immunofluorescence (mouse, 4E10, MBL Interna-
tional) and for immunoblot (rabbit, Novus Biochemical), p62
(mouse, p62 lck ligand, BDTransduction Laboratories), pEGFR
(rabbit, D7A5, Cell Signaling), EGF receptor (EGFR) (rabbit,
D38B1, Cell Signaling), pErk1/2 (mouse, clone MAPK-YT,
Sigma), Erk1/2 (mouse, clone 9B3, Abcam), Oregon Green
(rabbit, Invitrogen), ULK1 (rabbit, D8H5, Cell Signaling), phos-
pho-ULK1 (Ser-757) (rabbit, Cell Signaling), p70 S6K (rabbit,
49D7, Cell Signaling), phospho-p70 S6K (Thr-389) (rabbit,
108D2, Cell Signaling). Secondary antibodies for immunofluo-
rescence labeled with AlexaFluor dyes were all purchased from
Invitrogen, and HRP-coupled antibodies for immunoblotting
were from Dianova/Jackson ImmunoResearch.
The following siRNAs were used to knockdown protein
expression: GUA ACU GUC GGC UCG UGG UTT (scram-
bled); CCU GAU UGA GAU UCA GUG C (caveolin 1 single
siRNA); a) CUA AAC ACC UCA ACG AUG A, b) GCA AAU
ACGUAGACUCGGA, c) GCAGUUGUACCAUGCAUU
A, d) GCA UCA ACU UGC AGA AAG A (caveolin 1 smart-
pool from Thermo Scientific); GCA ACU GAC CAA CCA
CAU CTT (dynamin2); AUC CAA UUC GAA GAC CAA U
(clathrin heavy chain) and CAC ACU GAC CCU CAA UGU
C (flotillin 1).
ElectronMicroscopy
Glutaraldehyde-fixed HeLa cells treated with SiNPs were
dehydrated and embedded in epoxy resin for subsequent elec-
tron microscopic analysis.
Autophagy Assays
Procedure for Fluorescence Microscopy—Cells were incu-
bated with 20 g ml1 and 100 g ml1 SiNPs for 24 h. 4 h
before incubation was stopped, serum-free medium was added
together with 100 nM bafilomycin A1 (Sigma) to the corre-
sponding samples. After washing with ice-cold PBS, cells were
paraformaldehyde-fixed and processed for immunostaining
with LC3. Digitonin (Invitrogen) was used to permeabilize the
cells for LC3 staining. Imageswere takenwith a confocalmicro-
FIGURE 10. Schematicmodel illustrating the effect of SiNPs on the endolysosomal system.Under control conditions (SiNPs, left), receptor-bound EGF is
sorted into late endosomes (LE), which eventually fuse with lysosomes. LC3- and p62-containing autophagosomes also fuse with lysosomes for degradation.
SiNP accumulation in lysosomes (SiNPs, right) inhibits fusion of both late endosomes and autophagosomes with lysosomes, resulting in impaired degrada-
tion of EGF/EGFR and elevated levels of LC3- and p62-positive autophagosomes.
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scope LSM710 (Zeiss). Approximately 40 cells were analyzed
per assay in ImageJ under identical threshold conditions.
Immunoblotting—After nanoparticle incubation (see above)
cells were lysed on ice for 30–60 min in lysis buffer (2% Triton
X-100, 20 mMHEPES, pH 7.4, 100 mM KCl, 4 mMMgCl2, 1 mM
PMSF, 0.03% protease inhibitor mixture (Sigma); PMSF and
protease inhibitor mixture were added freshly). Crude cell
lysates were analyzed by SDS-PAGE and immunoblotting.
Band intensities were quantified using Fiji and Licor odyssey
software.
Lysosomal pHMeasurements
Lysosomal pH was determined by ratiometric fluorescence
imaging using a pH-sensitive Oregon Green 488 dye coupled
to a 10-kDa dextran (OGD; Molecular Probes). A standard
pulse-chase protocol was used to specifically target the fluoro-
phore to lysosomes. Therefore, cells were grown on MatTek
glass-bottom dishes to a confluence of 80%. The PBS-washed
cells were treated with 20 g of ml1 SiNPs (FITC) for 4 h in
DMEM (10% FBS). After two additional PBS washing steps,
0.5 mg/ml OGD was loaded onto the cells and incubated over-
night in DMEM (10% FBS). The next day cells were washed
with PBS, and the pH-sensitive dye was chased into lysosomes
for 2 h at 37 °C in DMEM (10% FBS). Control experiments
were conducted to prove the localization of Oregon Green to
LAMP1- and CD63-positive structures. The fluorophore was
excited at a wavelength of 440 and 488 nm, respectively, and
ratiometric fluorescence imageswere acquiredwith an inverted
microscope (Zeiss Axiovert 200 equippedwith a 100 1.30NA
oil immersion objective) connected to a Polychrom II mono-
chromator (TILL photonics). After passing a 535  20-nm fil-
ter, the emitted light was captured with a Sensicam CCD cam-
era (PCO Inc., Kelheim, Germany). For each sample (control
andNPs) at least 10 different cells were measured in imaging
solution (10 mM glucose, 2 mM CaCl2, 1 mM MgCl2, 135 mM
NaCl, 5 mM KCl, 10 mM HEPES, pH 7.4). Image analysis was
performed using a self-programmed Macro for Fiji ImageJ.
Therefore, regions of interest (ROIs) were defined as areas
above a certain fluorescence threshold in the acquired images at
488-nm excitation to then calculate the ratio of themean inten-
sity of the 488 and the 440 channel for each ROI. To finally
evaluate the pH for eachmeasurement, an in situpHcalibration
was conducted at the end of each experiment by treating the
cellswith isotonicK-based solutions (5mMNaCl, 1mMCaCl2,
115 mM KCl, 1.2 mM MgSO4, 10 mM glucose, 25 mM of either
HEPES, MES, or potassium acetate) ranging in pH from 3.5 to
7.0 and supplemented with 10 M concentrations of both nige-
ricin (Tocris Bioscience) and monensin (Sigma). The resulting
fluorescence intensity ratio (488 nm/440 nm) was fitted with a
sigmoidal function and used to interpolate the pH value from
the experimental ratio data.
Analysis of Cell Viability and Cytotoxicity
MTT Assay to Measure Metabolic Activity—HeLa cells were
seeded in 96-well plates at a density of 10,000 cells per well. The
next day cells were incubated for 24 h with different concentra-
tions of SiNPs (FITC). Afterward, cells were washed twice
with PBS. The addition of MTT (3-[4,5-dimethyltiazol-2-yl]
2,5-diphenyl-tetrazolium bromide), and following procedure
was carried out according to manufacturer’s instructions
(Invitrogen). The absorbance was measured at 562 nm with a
Safire2 plate reader (Tecan AG).
TUNEL Apoptosis Assay—Apoptosis was assayed by the
TUNEL Apoptosis Detection kit (Invitrogen Click-iTunel
AlexaFluor 647 ImagingAssay) according to the providedman-
ual. Briefly, HeLa cells were seeded in 96-well plates. Asynchro-
nously growing cells were treated in the presence or absence of
SiNPs at the indicated concentration for 24 h. Cells were
washed, fixed with 4% paraformaldehyde, permeabilized in
PBS, 0.25% Triton X-100, and processed for TUNEL staining
according to the manufacturer’s protocol. Cells treated with
DNase I for 15 min served as a positive control. Samples were
analyzed by epifluorescence microscopy and quantified.
Lactate Dehydrogenase Activity-based Necrosis Assay—Tox-
icity due to membrane permeabilization (necrosis) was assayed
by determination of lactate dehydrogenase activity using the
TaKaRa LDH Cytotoxicity Kit. HeLa cells were seeded in
96-well plates. Asynchronously growing cells were treated in
the presence or absence of SiNPs at the indicated concentration
for 24 h. The supernatant (100 l) was incubated with lactate
dehydrogenase assay reagent according to the manufacturer’s
protocol and measured at 490 nm (plate background absor-
bance) using Tecan Safire plate reader. Values were normalized
to drug/media background value, and toxicity was calculated as
a % of a 100% Triton X-100-lysed cell control (100% necrosis).
EGFR Signaling—HeLa cells at a confluence of 90% were
incubated with 20 g/ml SiNPs for 4 h, then washed and
starved inDMEM for 2 h. The sampleswere then stimulated for
0 and 30 min with 500 ng/ml unlabeled EGF in DMEM supple-
mented with 10 g/ml cycloheximide. Subsequently cells were
washed and lysed (1% Triton X-100, 20 mMHEPES pH 7.4, 100
mM KCl, 2 mM MgCl2, 1 mM PMSF, 0.03% protease inhibitor
mixture (Sigma); PMSF and protease inhibitor mixture were
added freshly). Phosphatase inhibitor mixture (Sigma) was
added for the analysis of phosphorylated proteins. Lysates were
spun at 20,000 g for 10min to get rid of cell nuclei, and debris
and supernatants were then analyzed by SDS/PAGE and
immunoblotting.
EGF Degradation Assay—After SiNPs incubation (as
described above), cells were washed three times with PBS and
then conducted to starvation for 2 h in DMEM followed by
incubation with 100 ng/ml EGF-Alexa647 (Molecular Probes)
for 30 min on ice. Cells were then washed 2 times with ice-cold
PBS and incubated in DMEM for 30, 60, and 120 min at 37 °C.
Immediately afterward, cells were washed on ice and processed
for immunocytochemistry. To evaluate EGFR levels, coverslips
were paraformaldehyde fixed right after the 30min on ice incu-
bation with EGF-Alexa647.
Transferrin Recycling Assay—After incubation with SiNPs,
cells were washed 3 times with PBS and then starved for 1 h in
DMEM followed by incubation with 20 g/ml Tf-Alexa647
(Molecular Probes) for 30 min on ice. Subsequently cells were
washed 2 times with ice-cold PBS and incubated in DMEM for
5, 15, and 60 min at 37 °C. Immediately afterward, cells were
washed on ice and processed for immunocytochemistry. To
evaluate transferrin (Tf) receptor levels, coverslips were para-
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formaldehyde-fixed right after the 30 min on ice incubation
with Tf-Alexa647.
LysoTracker—Cells were grown overnight on coverslips,
washed once with PBS, and incubated with 20 g/ml SiNPs in
DMEM (10% FBS) supplemented with 50 nM LysoTracker
Red DND-99 (Invitrogen) for 4 h at 37 °C. Afterward cells were
washed thoroughly with PBS and imaged live in HBSS, 10 mM
HEPES at 37 °C and 5% CO2.
Cathepsin B/L Lysosomal Protease Activity—Cells were
seeded on MatTek glass-bottom dishes (MatTek Corp.) and
cultured overnight at 37 °C and 5% CO2. Washed cells were
then incubated with 20g/ml SiNPs in DMEM (10% FBS) for
4 h, washed thoroughly, and subsequently treated according to
the manufacturer’s protocol. The total incubation time with
Magic RedTM Cathepsin B/L (both from Immunochemistry
Technologies) was 60 min at 37 °C and 5% CO2. Hoechst was
added directly to cells 15 min before imaging.
Data Analysis and Statistics—Data are expressed as the
means  S.E. of at least three experiments. The statistical sig-
nificance was assessed by using the unpaired t test.
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